Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.680
-0.010 (-0.27%)
Apr 29, 2026, 3:00 PM CST

SHA:600664 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,2938,68910,4018,4457,5998,940
Market Cap Growth
0.82%-16.46%23.17%11.14%-15.00%11.79%
Enterprise Value
8,1077,9449,8348,3738,60810,444
Last Close Price
3.693.454.133.353.013.55
PE Ratio
30.8424.0316.5421.3716.3424.09
Forward PE
-14.9114.9114.9114.9114.91
PS Ratio
0.580.540.640.550.550.70
PB Ratio
1.401.351.711.561.542.02
P/TBV Ratio
1.721.662.122.001.982.69
P/FCF Ratio
16.4230.1015.049.7814.27-
P/OCF Ratio
12.9419.7613.138.8912.22-
EV/Sales Ratio
0.510.500.610.540.620.82
EV/EBITDA Ratio
8.798.289.239.5310.4814.57
EV/EBIT Ratio
11.9210.8811.5713.5415.4323.33
EV/FCF Ratio
14.3327.5214.229.7016.17-
Debt / Equity Ratio
0.180.190.290.340.440.52
Debt / EBITDA Ratio
1.321.281.582.012.483.06
Debt / FCF Ratio
2.164.312.552.154.04-
Net Debt / Equity Ratio
-0.30-0.34-0.31-0.22-0.060.16
Net Debt / EBITDA Ratio
-2.15-2.29-1.76-1.37-0.351.01
Net Debt / FCF Ratio
-3.47-7.60-2.71-1.39-0.53-3.01
Asset Turnover
1.111.111.131.121.051.04
Inventory Turnover
5.985.986.116.145.405.01
Quick Ratio
1.121.121.080.990.930.82
Current Ratio
1.451.441.361.261.201.11
Return on Equity (ROE)
5.27%6.35%12.00%9.15%10.94%9.75%
Return on Assets (ROA)
2.96%3.16%3.70%2.81%2.65%2.27%
Return on Invested Capital (ROIC)
10.23%11.99%15.90%10.15%8.31%5.82%
Return on Capital Employed (ROCE)
9.70%10.60%13.10%10.50%10.30%9.00%
Earnings Yield
3.33%4.16%6.05%4.68%6.12%4.15%
FCF Yield
6.09%3.32%6.65%10.22%7.01%-2.67%
Payout Ratio
8.17%9.21%7.49%11.17%11.68%16.59%
Buyback Yield / Dilution
-1.54%-2.68%-1.82%4.40%-4.46%1.29%
Total Shareholder Return
-1.54%-2.68%-1.82%4.40%-4.46%1.29%
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.